Eli Lilly’s Zepbound is off to a strong start, but here’s what needs to happen to push shares higher
Investors will be tuning into the company's fourth quarter earnings call on Feb. 6, eager to hear more about how
Read More
obesity
These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass
Piper Sandler analyst Allison Bratzel said the loss of lean muscle while taking GLP-1 drugs is "a major shortcoming" that
Read More
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs. Source link
Read More
Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion
The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by
Read More
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Danuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection
Read More
UK obesity levels to keep rising as sufferers have little choice amid cost-of-living crisis
LONDON Obesity is on track to become a major health issue for British people, with 60% of men and 50%
Read More
One in every three Turks clinically obese: Report – Turkey News
One in every three Turks clinically obese: Report Hurriyet Daily News Source link
Read More